This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Galli, M. Articles by Barbui, T. Search for Related Content PubMed PubMed Citation Articles by Galli, M. Articles by Barbui, T. Social Bookmarking                         What's this?

Review : Prothrombin as cofactor for antiphospholipids

Divisione di Ematologia, Ospedali Riuniti, Bergamo, Italy

T. Barbui

Divisione di Ematologia, Ospedali Riuniti, Bergamo, Italy

Prothrombin is a common antigenic target of antiphospholipid antibodies, since anti-prothrombin antibodies are detected in about 50-90% of the patients. To allow proper immune recognition, prothrombin must be adsorbed on suitable anionic surfaces. The epitope(s) have not yet been identified: the majority of anti-prothrombin antibodies appear to be of poly- or oligoclonal nature. Anti-prothrombin antibodies, either alone or in combination with anti-β2-glycoprotein I antibodies, are responsible for the lupus anticoagulant activity of about 75% of the cases of phospholipid- dependent inhibitors of coagulation. The two antibodies may be discriminated by means of specific coagulation profiles generated by the comparison of the ratio of the Kaolin Clotting Time (KCT) and the dilute Russell's Viper Venom Time (dRVVT): the KCT profile, which mainly reflects the presence of anti-prothrombin antibodies and the dRVVT profile, which is mostly associated with anti-β2-glycoprotein I antibodies. This distinction, although somewhat artificial, may be clinically useful, since the KCT profile identifies patients at low risk to develop thrombosis. Similarly, most of the studies that measured anti-prothrombin antibodies by ELISA failed to find a significant association with thrombosis. In conclusion, the clinical relevance of these antibodies has not yet been established.

Lupus, Vol. 7, No. 2 suppl, S37-S40 (1998)
DOI: 10.1177/096120339800700209


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T P Greco, M D Amos, A M Conti-Kelly, J D Naranjo, and J W Ijdo Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I Lupus, January 1, 2000; 9(1): 33 - 41. [Abstract] [PDF]